Merck Market Cap 2006-2018 | MRK

Merck market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Merck market cap as of October 16, 2018 is $187.28B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $187.277B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $359.375B 17.17
Pfizer (PFE) United States $256.688B 15.02
Novartis AG (NVS) Switzerland $192.696B 16.53
AbbVie (ABBV) United States $135.043B 13.19
Eli Lilly (LLY) United States $118.805B 21.99
Sanofi (SNY) France $108.926B 13.79
Novo Nordisk (NVO) Denmark $103.361B 16.52
GlaxoSmithKline (GSK) United Kingdom $96.420B 12.87
AstraZeneca (AZN) United Kingdom $94.908B 10.44
Bristol-Myers Squibb (BMY) United States $94.166B 17.04